W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® CONFORMABLE AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
|
Back to Search Results |
|
Catalog Number CXT261412 |
Device Problems
Patient-Device Incompatibility (2682); Device-Device Incompatibility (2919)
|
Event Date 03/04/2024 |
Event Type
Injury
|
Manufacturer Narrative
|
H3: code "other" was selected as the medical device remains implanted.Return not possible.H6: a review of the manufacturing records for the device verified that the lot met all pre-release specifications.H6: code d12: according to the gore® excluder® conformable aaa endoprosthesis for use (ifu), adverse events that may occur and/or require intervention include, but are not limited to: endoleak.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Event Description
|
The following information was reported to gore: on (b)(6) 2023, this patient underwent endovascular treatment of an abdominal aortic aneurysm using gore® excluder® aaa endoprostheses.On an unknown date after the initial procedure, during follow-up, a proximal type i endoleak and a type iiia endoleak from the contralateral gate of the trunk - ipsilateral leg endoprosthesis were suspected.On (b)(6) 2024, a reintervention was performed.No clear endoleak was identified by angiography, but ct and ultrasonography showed endoleak, so additional stent grafts were implanted in the proximal side of the trunk - ipsilateral leg endoprosthesis and in the overlap part of the contralateral gate as planned.In addition, a type ii endoleak was also suspected, so the inferior mesenteric artery was coil embolised.The patient tolerated the procedure.Reportedly, the proximal neck was angulated and severe calcification was observed from preoperatively.
|
|
Search Alerts/Recalls
|
|
|